Mathieu Rouanne

8.1k total citations · 6 hit papers
69 papers, 4.6k citations indexed

About

Mathieu Rouanne is a scholar working on Surgery, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mathieu Rouanne has authored 69 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Surgery, 25 papers in Oncology and 18 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mathieu Rouanne's work include Bladder and Urothelial Cancer Treatments (38 papers), Urinary and Genital Oncology Studies (27 papers) and Cancer Immunotherapy and Biomarkers (18 papers). Mathieu Rouanne is often cited by papers focused on Bladder and Urothelial Cancer Treatments (38 papers), Urinary and Genital Oncology Studies (27 papers) and Cancer Immunotherapy and Biomarkers (18 papers). Mathieu Rouanne collaborates with scholars based in France, United States and Netherlands. Mathieu Rouanne's co-authors include Y. Neuzillet, Éva Compérat, Erik Veskimäe, Georgios Gakis, Nigel C. Cowan, Antoine G. van der Heijden, María J. Ribal, J. Alfred Witjes, Virginia Hernández and Estefanía Linares and has published in prestigious journals such as Nature, Science and Nature Communications.

In The Last Decade

Mathieu Rouanne

67 papers receiving 4.6k citations

Hit Papers

European Association of Urology Guidelines on Muscle... 2016 2026 2019 2022 2020 2016 2021 2023 2024 400 800 1.2k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mathieu Rouanne France 24 3.1k 1.2k 1.2k 968 955 69 4.6k
Viktor Soukup Czechia 19 4.5k 1.4× 975 0.8× 897 0.8× 985 1.0× 1.3k 1.4× 57 5.2k
Otakar Čapoun Czechia 17 4.1k 1.3× 931 0.8× 854 0.7× 912 0.9× 1.2k 1.2× 57 4.8k
Fredrik Liedberg Sweden 35 4.6k 1.5× 1.2k 1.0× 1.5k 1.3× 1.7k 1.8× 945 1.0× 175 5.8k
Richard Cathomas Switzerland 28 2.0k 0.6× 1.5k 1.3× 1.3k 1.1× 1.1k 1.2× 410 0.4× 149 4.0k
Amir Sherif Sweden 28 3.5k 1.1× 1.1k 0.9× 752 0.6× 597 0.6× 1.3k 1.4× 105 4.3k
Eero Kaasinen Finland 24 6.1k 2.0× 1.2k 1.0× 1.0k 0.9× 1.1k 1.1× 2.0k 2.1× 39 6.8k
Dragan Golijanin United States 33 1.5k 0.5× 628 0.5× 1.5k 1.2× 1.2k 1.2× 535 0.6× 110 4.0k
Mark Schoenberg United States 53 6.6k 2.1× 1.9k 1.6× 1.6k 1.4× 2.2k 2.3× 2.4k 2.5× 218 9.1k
M. Craig Hall United States 28 1.5k 0.5× 748 0.6× 1.3k 1.1× 1.2k 1.2× 488 0.5× 57 3.4k
Karl‐Heinz Kurth Netherlands 21 3.3k 1.1× 669 0.6× 548 0.5× 587 0.6× 1.1k 1.2× 41 4.1k

Countries citing papers authored by Mathieu Rouanne

Since Specialization
Citations

This map shows the geographic impact of Mathieu Rouanne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mathieu Rouanne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mathieu Rouanne more than expected).

Fields of papers citing papers by Mathieu Rouanne

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mathieu Rouanne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mathieu Rouanne. The network helps show where Mathieu Rouanne may publish in the future.

Co-authorship network of co-authors of Mathieu Rouanne

This figure shows the co-authorship network connecting the top 25 collaborators of Mathieu Rouanne. A scholar is included among the top collaborators of Mathieu Rouanne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mathieu Rouanne. Mathieu Rouanne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Fangda, Thomas Savage, Rosa L. Vincent, et al.. (2024). Programmable bacteria synergize with PD-1 blockade to overcome cancer cell–intrinsic immune resistance mechanisms. Science Immunology. 9(100). eadn9879–eadn9879. 13 indexed citations
2.
Vincent, Rosa L., Candice R. Gurbatri, Fangda Li, et al.. (2023). Probiotic-guided CAR-T cells for solid tumor targeting. Science. 382(6667). 211–218. 146 indexed citations breakdown →
3.
Chung, Rainjade, James M. McKiernan, Nicholas Arpaia, Aurélien Marabelle, & Mathieu Rouanne. (2023). Neo-Adjuvant immunotherapies: Bladder cancer as a platform for drug development targeting mucosal immunity. European Journal of Cancer. 187. 58–64. 7 indexed citations
4.
Goubet, Anne‐Gaëlle, Mathieu Rouanne, Lisa Derosa, Guido Kroemer, & Laurence Zitvogel. (2023). From mucosal infection to successful cancer immunotherapy. Nature Reviews Urology. 20(11). 682–700. 9 indexed citations
5.
Neuzillet, Y., Mathieu Rouanne, Jean‐François Dreyfus, et al.. (2021). Metabolic syndrome, levels of androgens, and changes of erectile dysfunction and quality of life impairment 1 year after radical prostatectomy. Asian Journal of Andrology. 23(4). 370–375. 1 indexed citations
6.
Kossaï, Myriam, C. Radulescu, Julien Adam, et al.. (2021). Plasmacytoid urothelial carcinoma (UC) are luminal tumors with similar CD8+ Tcell density and PD-L1 protein expression on immune cells as compared to conventional UC. Urologic Oncology Seminars and Original Investigations. 40(1). 12.e1–12.e11. 9 indexed citations
7.
Mezquita, Laura, Caroline Rossoni, Édouard Auclin, et al.. (2021). Tumour-infiltrating lymphocyte density is associated with favourable outcome in patients with advanced non–small cell lung cancer treated with immunotherapy. European Journal of Cancer. 145. 221–229. 53 indexed citations
8.
Cathomas, Richard, Anja Lorch, Harman Max Bruins, et al.. (2021). The 2021 Updated European Association of Urology Guidelines on Metastatic Urothelial Carcinoma. European Urology. 81(1). 95–103. 212 indexed citations breakdown →
9.
Chabanon, Roman M., Mathieu Rouanne, Christopher J. Lord, et al.. (2021). Targeting the DNA damage response in immuno-oncology: developments and opportunities. Nature reviews. Cancer. 21(11). 701–717. 192 indexed citations
10.
Bruins, H.M., Erik Veskimäe, Virginia Hernández, et al.. (2020). Radical cystectomy: The significance of hospital volume and surgeon volume. A systematic review and recommendations by the EAU MIBC Guideline Panel. European Urology Open Science. 19. e1790–e1791.
11.
Rouanne, Mathieu, C. Radulescu, Julien Adam, & Yves Allory. (2020). PD-L1 testing in urothelial bladder cancer: essentials of clinical practice. World Journal of Urology. 39(5). 1345–1355. 12 indexed citations
12.
Witjes, J. Alfred, Harman Max Bruins, Richard Cathomas, et al.. (2020). European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines. European Urology. 79(1). 82–104. 1278 indexed citations breakdown →
13.
Rouanne, Mathieu, F. Gaillard, M Meunier, et al.. (2020). Measured glomerular filtration rate (GFR) significantly and rapidly decreases after radical cystectomy for bladder cancer. Scientific Reports. 10(1). 16145–16145. 5 indexed citations
14.
Sim, Wen Jing, Prasanna Vasudevan Iyengar, Dilraj Lama, et al.. (2019). c-Met activation leads to the establishment of a TGFβ-receptor regulatory network in bladder cancer progression. Nature Communications. 10(1). 4349–4349. 48 indexed citations
15.
Mezquita, Laura, Caroline Rossoni, Édouard Auclin, et al.. (2019). MA25.03 Tumor-Infiltrating Lymphocytes (TIL) and Outcomes with Immunotherapy (ICI) or Chemotherapy in Advanced NSCLC (aNSCLC) Patients. Journal of Thoracic Oncology. 14(10). S351–S352. 2 indexed citations
16.
Simon, Marie, Mathieu Rouanne, Simone Benhamou, et al.. (2019). Multiple recurrences and risk of disease progression in patients with primary low-grade (TaG1) non–muscle-invasive bladder cancer and with low and intermediate EORTC-risk score. PLoS ONE. 14(2). e0211721–e0211721. 19 indexed citations
17.
Meunier, M, Y. Neuzillet, C. Radulescu, et al.. (2018). Le delai entre biopsies de prostate et prostatectomie radicale influence-t-il le risque de recidive ?. Progrès en Urologie. 28(10). 475–481. 10 indexed citations
18.
Rouanne, Mathieu, Julien Adam, Aïcha Goubar, et al.. (2016). Osteopontin and thrombospondin-1 play opposite roles in promoting tumor aggressiveness of primary resected non-small cell lung cancer. BMC Cancer. 16(1). 483–483. 32 indexed citations
19.
Rouanne, Mathieu, J. Rode, Yves Allory, et al.. (2013). Long-term impact of positive surgical margins on biochemical recurrence after radical prostatectomy: Ten years of follow-up. Scandinavian Journal of Urology. 48(2). 131–137. 15 indexed citations
20.
Rouanne, Mathieu, et al.. (2011). Management of Renal Cell Carcinoma in Sigmoid Kidney. Urologia Internationalis. 88(4). 483–485. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026